Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center.
J Arrhythm
; 33(4): 338-341, 2017 Aug.
Article
in En
| MEDLINE
| ID: mdl-28765769
ABSTRACT
BACKGROUND:
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is recognized as a viable alternative to the transvenous ICD. The safety and efficacy of this device has been demonstrated in Western countries, but studies with S-ICD implantation in Japanese patients have not been reported. METHODS ANDRESULTS:
Twelve patients received an S-ICD implant in our institute between February and September 2016. All S-ICDs were successfully implanted without complications. One appropriate and one inappropriate therapy was identified.CONCLUSIONS:
S-ICD implantation appears to provide a viable alternative to transvenous ICD implantation for some Japanese patients. However, we should perform careful follow-up of patients to eliminate inappropriate therapy.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Arrhythm
Year:
2017
Document type:
Article
Affiliation country:
Japan